Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39357) 39357
Publication (3811) 3811
Newspaper Article (1915) 1915
Newsletter (1692) 1692
Book Review (561) 561
Book Chapter (357) 357
Magazine Article (233) 233
Book / eBook (117) 117
Dissertation (60) 60
Conference Proceeding (59) 59
Trade Publication Article (51) 51
Transcript (36) 36
Government Document (31) 31
Report (30) 30
Web Resource (27) 27
Reference (25) 25
Data Set (10) 10
Paper (4) 4
Presentation (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30726) 30726
index medicus (18033) 18033
female (14773) 14773
male (14246) 14246
hepatitis (13278) 13278
adult (11810) 11810
middle aged (9718) 9718
hepatitis b (7842) 7842
health aspects (7683) 7683
hepatitis c (7156) 7156
gastroenterology & hepatology (6920) 6920
risk factors (6809) 6809
infection (6335) 6335
hepatitis c virus (6195) 6195
infectious diseases (6031) 6031
infections (5959) 5959
prevalence (5158) 5158
hepatitis b virus (5101) 5101
hepatitis b - prevention & control (4954) 4954
aged (4891) 4891
adolescent (4628) 4628
animals (4609) 4609
viruses (4520) 4520
research (4479) 4479
immunology (4351) 4351
antiviral agents - therapeutic use (4255) 4255
prevention (4197) 4197
virology (4180) 4180
epidemiology (4168) 4168
liver (4108) 4108
hiv (4019) 4019
vaccination (4005) 4005
analysis (3864) 3864
virus diseases (3720) 3720
young adult (3200) 3200
human immunodeficiency virus--hiv (3156) 3156
child (3049) 3049
liver diseases (2969) 2969
interferon (2966) 2966
public health (2855) 2855
medicine (2814) 2814
care and treatment (2813) 2813
risk (2773) 2773
hepatitis c - epidemiology (2747) 2747
vaccines (2706) 2706
research article (2686) 2686
medical research (2678) 2678
virus-infection (2641) 2641
hepatitis b - epidemiology (2617) 2617
treatment outcome (2589) 2589
hepatocellular-carcinoma (2547) 2547
liver cancer (2528) 2528
immunization (2515) 2515
united-states (2456) 2456
cirrhosis (2359) 2359
mortality (2348) 2348
antiviral agents (2329) 2329
hepatocellular carcinoma (2327) 2327
genotype (2315) 2315
disease (2247) 2247
medicine, general & internal (2211) 2211
digestive system diseases (2193) 2193
retrospective studies (2155) 2155
public, environmental & occupational health (2147) 2147
microbiology (2132) 2132
therapy (2097) 2097
cancer (2071) 2071
liver cirrhosis (2043) 2043
child, preschool (2017) 2017
infant (2013) 2013
hepatitis-c virus (2006) 2006
medicine, experimental (2000) 2000
studies (1999) 1999
transplantation (1988) 1988
hepacivirus - genetics (1977) 1977
antigens (1952) 1952
hepatitis b virus - genetics (1951) 1951
transmission (1933) 1933
antibodies (1932) 1932
patients (1916) 1916
medicine & public health (1908) 1908
diagnosis (1885) 1885
hepatitis b virus - immunology (1882) 1882
hepatitis c - prevention & control (1882) 1882
pregnancy (1868) 1868
drug therapy (1858) 1858
oncology (1843) 1843
article (1828) 1828
incidence (1808) 1808
medicine, research & experimental (1784) 1784
risk-factors (1749) 1749
hcv (1746) 1746
proteins (1746) 1746
multidisciplinary sciences (1744) 1744
mice (1712) 1712
human-immunodeficiency-virus (1707) 1707
virus (1703) 1703
hepatitis c, chronic - drug therapy (1700) 1700
hepatology (1697) 1697
time factors (1680) 1680
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (70) 70
Online Resources - Online (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Mississauga - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41757) 41757
French (484) 484
German (381) 381
Russian (227) 227
Spanish (196) 196
Japanese (156) 156
Chinese (154) 154
Polish (84) 84
Italian (75) 75
Czech (47) 47
Korean (40) 40
Hungarian (33) 33
Dutch (31) 31
Portuguese (29) 29
Danish (25) 25
Croatian (24) 24
Turkish (19) 19
Romanian (18) 18
Swedish (17) 17
Hebrew (11) 11
Norwegian (11) 11
Arabic (7) 7
Finnish (7) 7
Serbian (7) 7
Bosnian (5) 5
Slovak (3) 3
Slovenian (3) 3
Urdu (3) 3
Greek (2) 2
Thai (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
by Dolan, Kate, Prof and Wirtz, Andrea L, PhD and Moazen, Babak, MScIH and Ndeffo-mbah, Martial, PhD and Galvani, Alison, Prof and Kinner, Stuart A, Prof and Courtney, Ryan, PhD and McKee, Martin, Prof and Amon, Joseph J, PhD and Maher, Lisa, Prof and Hellard, Margaret, Prof and Beyrer, Chris, Prof and Altice, Fredrick L, Prof
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10049, pp. 1089 - 1102
Summary The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We... 
Internal Medicine | MASS INCARCERATION | UNITED-STATES | B-VIRUS | CORRECTIONAL FACILITY | MEDICINE, GENERAL & INTERNAL | INJECTION-DRUG USERS | SEXUALLY-TRANSMITTED INFECTIONS | HUMAN-RIGHTS | SUBSTANCE USE | RHODE-ISLAND | C VIRUS | Tuberculosis - epidemiology | HIV Infections - prevention & control | United States - epidemiology | Drug Users - legislation & jurisprudence | Prevalence | HIV Infections - epidemiology | Humans | Tuberculosis - etiology | Cost of Illness | Hepatitis B - epidemiology | Prisoners - statistics & numerical data | Hepatitis, Viral, Human - epidemiology | Global Health - trends | Hepatitis C - epidemiology | Global Health - statistics & numerical data | HIV Infections - transmission | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Hepatitis, Viral, Human - etiology | Coinfection - epidemiology | Hepatitis, Viral, Human - prevention & control | HIV Infections - etiology | Tuberculosis - prevention & control | Disease Outbreaks - prevention & control | Hepatitis C - etiology | Prevention | Tuberculosis | Analysis | Detention of persons | Hepatitis C virus | Hepatitis C | HIV (Viruses) | Health aspects | Epidemiology | Prisoners | Epidemics | Hepatitis | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Imprisonment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
by Williams, Roger, Prof and Aspinall, Richard, MBChB and Bellis, Mark, Prof and Camps-Walsh, Ginette, DMS and Cramp, Matthew, Prof and Dhawan, Anil, Prof and Ferguson, James, MD and Forton, Dan, PhD and Foster, Graham, Prof and Gilmore, Sir Ian, Prof and Hickman, Matthew, Prof and Hudson, Mark, FRCP and Kelly, Deirdre, Prof and Langford, Andrew, PhD and Lombard, Martin, Prof and Longworth, Louise, PhD and Martin, Natasha, DPhil and Moriarty, Kieran, FRCP and Newsome, Philip, Prof and O'Grady, John, Prof and Pryke, Rachel, MRCGP and Rutter, Harry, MB BChir and Ryder, Stephen, FRcP and Sheron, Nick, Prof and Smith, Tom, PhD
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9958, pp. 1953 - 1997
Liver disease in the UK stands out as the one glaring exception to the vast improvements made during the past 30 years in health and life expectancy for... 
Internal Medicine | 15-YEAR FOLLOW-UP | MEDICINE, GENERAL & INTERNAL | OPIATE SUBSTITUTION THERAPY | COST-EFFECTIVENESS | ADVERSE CHILDHOOD EXPERIENCES | C VIRUS-INFECTION | ADVANCED FIBROSIS | B SURFACE-ANTIGEN | SYRINGE PROGRAMS | NATURAL-HISTORY | BILIARY ATRESIA | Critical Care - standards | Gastroenterology - standards | Humans | Middle Aged | Socioeconomic Factors | Liver Transplantation - standards | Nurse Clinicians - supply & distribution | Young Adult | Adult | Obesity - mortality | Alcohol Drinking - prevention & control | Risk Reduction Behavior | Liver Diseases - prevention & control | Liver Diseases, Alcoholic - prevention & control | Hospitalization | Delivery of Health Care - standards | Hepatitis, Viral, Human - prevention & control | Mortality, Premature | Liver Transplantation - statistics & numerical data | Liver Diseases, Alcoholic - mortality | Residence Characteristics - statistics & numerical data | Obesity - prevention & control | Adolescent | Healthcare Disparities | Liver Diseases - mortality | Aged | Hepatitis, Viral, Human - mortality | Early Diagnosis | United Kingdom - epidemiology | Quality of Health Care | Alcohol Drinking - mortality | Causes of | Liver diseases | Demographic aspects | Patient outcomes | Health care | Obesity | Hepatitis | Mortality | Alcohol use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Hepatitis prevention and treatment
by Colacino, J. M. 1953- (Joseph M.) and Heinz, Beverly A
2004, Milestones in drug therapy, ISBN 9783764359560, xi, 246
Hepatitis, Viral | Antiviral Agents | drug therapy | prevention & control | therapeutic use | Hepatitis, Viral, Human
Book
Details down arrow
4. Full Text ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease
by Farraye, Francis A and Melmed, Gil Y and Lichtenstein, Gary R and Kane, Sunanda V
American Journal of Gastroenterology, ISSN 0002-9270, 02/2017, Volume 112, Issue 2, pp. 241 - 258
Recent data suggest that inflammatory bowel disease (IBD) patients do not receive preventive services at the same rate as general medical patients. Patients... 
IMMUNE-RESPONSE | ADVISORY-COMMITTEE | HEPATITIS-B-VIRUS | NONMELANOMA SKIN-CANCER | CROHNS-DISEASE | INCREASED RISK | BASAL-CELL CARCINOMA | ULCERATIVE-COLITIS | INFLUENZA VACCINATION | GASTROENTEROLOGY & HEPATOLOGY | IMMUNIZATION PRACTICES | Herpes Zoster - prevention & control | Melanoma - diagnosis | Herpes Zoster - etiology | Humans | Immunosuppressive Agents - therapeutic use | Osteoporosis - diagnosis | Male | Vaccines - therapeutic use | Anxiety - therapy | Preventive Medicine - methods | Meningococcal Infections - etiology | Skin Neoplasms - diagnosis | Anxiety - diagnosis | Female | Pneumococcal Infections - etiology | Papillomavirus Infections - etiology | Hepatitis, Viral, Human - etiology | Inflammatory Bowel Diseases - drug therapy | Uterine Cervical Neoplasms - diagnosis | Early Detection of Cancer | Uterine Cervical Neoplasms - prevention & control | Meningococcal Infections - prevention & control | Influenza, Human - etiology | Chickenpox - prevention & control | Chickenpox - etiology | Depression - diagnosis | Hepatitis, Viral, Human - prevention & control | Papillomavirus Infections - prevention & control | Pneumococcal Infections - prevention & control | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Primary Health Care | Depression - therapy | Influenza, Human - prevention & control | Immunologic Factors - therapeutic use | Smoking Cessation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Viral Hepatitis in HIV Infection
by Koziel, Margaret James and Peters, Marion G
The New England Journal of Medicine, ISSN 0028-4793, 04/2007, Volume 356, Issue 14, pp. 1445 - 1454
Liver disease due to chronic HBV or HCV infection is becoming a leading cause of death among persons with HIV infection. Both the risk of hepatocellular... 
MEDICINE, GENERAL & INTERNAL | IN-VITRO | COINFECTED PATIENTS | B CORE ANTIGEN | PEGINTERFERON ALPHA-2A | INTERFERON-ALPHA-2B PLUS RIBAVIRIN | ACTIVE ANTIRETROVIRAL THERAPY | C VIRUS | STAGE LIVER-DISEASE | PEGYLATED INTERFERON-ALPHA-2B | HUMAN-IMMUNODEFICIENCY-VIRUS | Liver - pathology | Hepatitis C - drug therapy | Polyethylene Glycols | Antiviral Agents - therapeutic use | Humans | AIDS-Related Opportunistic Infections - drug therapy | Interferon-alpha - therapeutic use | AIDS-Related Opportunistic Infections - diagnosis | Alanine Transaminase - blood | Recombinant Proteins | Hepatitis B - complications | Hepatitis B - diagnosis | Hepatitis C - diagnosis | Hepatitis, Viral, Human - prevention & control | Hepatitis Antibodies - blood | HIV Infections - complications | Hepatitis B - drug therapy | Hepatitis C - complications | Hepatitis B e Antigens - blood | Prevention | Causes of | Hepatitis | Care and treatment | HIV infection | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Towards elimination of viral hepatitis by 2030
by The Lancet
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10042, pp. 308 - 308
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(16)31144-8 Byline: The Lancet 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Hepatitis, Viral, Human - epidemiology | Hepatitis, Viral, Human - prevention & control | Global Health | Health Services Accessibility | Humans | Hepatitis | Disease prevention | Disease control | Public health | Viral infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety
by Bolton‐Maggs, Paula H. B and Cohen, Hannah
British Journal of Haematology, ISSN 0007-1048, 11/2013, Volume 163, Issue 3, pp. 303 - 314
Summary The Serious Hazards of Transfusion (SHOT) UK confidential haemovigilance reporting scheme began in 1996. Over the 16 years of reporting, the evidence... 
transfusion safety | haemovigilance | Serious Hazards of Transfusion | transfusion reactions | transfusion errors | Transfusion reactions | Haemovigilance | Transfusion errors | Transfusion safety | ERRORS | PREVENTION | SURVEILLANCE SYSTEM | NECROTIZING ENTEROCOLITIS | IMPACT | DISEASE | BLOOD-TRANSFUSION | HEMATOLOGY | HIV Infections - prevention & control | Anaphylaxis - prevention & control | Humans | Risk | Blood Transfusion - statistics & numerical data | Commission on Professional and Hospital Activities | North America | Hypertension - etiology | Mandatory Reporting | Bacteremia - prevention & control | Laboratories, Hospital - organization & administration | Hepatitis, Viral, Human - transmission | Acute Lung Injury - prevention & control | Blood Group Incompatibility - prevention & control | Blood Transfusion - standards | Blood Volume | Hypertension - prevention & control | HIV Infections - transmission | Anaphylaxis - etiology | Global Health | Anemia, Sickle Cell - complications | Disease Notification | Europe | United Kingdom | Blood Safety - utilization | Transfusion Reaction | Anemia, Sickle Cell - therapy | Hepatitis, Viral, Human - prevention & control | National Health Programs - organization & administration | Laboratories, Hospital - statistics & numerical data | International Agencies | Quality Improvement | Blood Banks - standards | Blood Safety - statistics & numerical data | Acute Lung Injury - etiology | Blood Banks - statistics & numerical data | Bacteremia - transmission | Laboratories, Hospital - standards | Reviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Joint society statement for the elimination of viral hepatitis
by Brahm, Javier and Castera, Laurent and Hou, Jinlin and Lindor, Keith
Hepatology, ISSN 0270-9139, 10/2016, Volume 64, Issue 4, pp. 1031 - 1032
GASTROENTEROLOGY & HEPATOLOGY | Hepatitis, Viral, Human - prevention & control | Public Health | Societies, Medical | Hepatitis, Viral, Human - therapy | Humans | Cost of Illness | Hepatitis, Viral, Human - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Viral Hepatitis in Solid Organ Transplantation
by Levitsky, J and Doucette, K and AST Infect Dis Community Practice and AST Infectious Diseases Community of Practice
American Journal of Transplantation, ISSN 1600-6135, 03/2013, Volume 13, Issue s4, pp. 147 - 168
varicella infections | acyclovir | viral infection | posttransplant infection | shingles | valacyclovir | SURGERY | PROSPECTIVE RANDOMIZED-TRIAL | ORTHOTOPIC LIVER-TRANSPLANTATION | B SURFACE-ANTIGEN | HBV-RELATED CIRRHOSIS | PREEMPTIVE ANTIVIRAL THERAPY | TRANSPLANTATION | VENOUS-PRESSURE GRADIENT | ANTIBODY-POSITIVE DONORS | C VIRUS-INFECTION | INTERFERON-ALPHA-2B PLUS RIBAVIRIN | RABBIT ANTITHYMOCYTE GLOBULIN | Hepatitis, Viral, Human - epidemiology | Hepatitis, Viral, Human - classification | Hepatitis, Viral, Human - prevention & control | Antiviral Agents - therapeutic use | Humans | Risk Factors | Organ Transplantation | Hepatitis, Viral, Human - drug therapy | Virus diseases | Transplantation of organs, tissues, etc | Hepatitis | Acyclovir
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights